Living better or living longer? perceptions of patients (PTS) and health care professionals (HCP) in ONCOLOGY (2014)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1093/annonc/mdu352.7
- Subjects: ONCOLOGIA; QUALIDADE DE VIDA; PERCEPÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Annals of Oncology
- ISSN: 0923-7534
- Volume/Número/Paginação/Ano: v. 25, suppl 4, res. 1375P, p. iv483, 2014
- Conference titles: Congress Scientific Comitee/ESMO
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TOLOI, D. A. et al. Living better or living longer? perceptions of patients (PTS) and health care professionals (HCP) in ONCOLOGY. Annals of Oncology. Dordrecht: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/annonc/mdu352.7. Acesso em: 17 fev. 2026. , 2014 -
APA
Toloi, D. A., Critchi, G., Mangabeira, A., Hoff, P. M., Matsushita, F., Saad, E. D., & Riechelmann, R. P. (2014). Living better or living longer? perceptions of patients (PTS) and health care professionals (HCP) in ONCOLOGY. Annals of Oncology. Dordrecht: Faculdade de Medicina, Universidade de São Paulo. doi:10.1093/annonc/mdu352.7 -
NLM
Toloi DA, Critchi G, Mangabeira A, Hoff PM, Matsushita F, Saad ED, Riechelmann RP. Living better or living longer? perceptions of patients (PTS) and health care professionals (HCP) in ONCOLOGY [Internet]. Annals of Oncology. 2014 ; 25 iv483.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1093/annonc/mdu352.7 -
Vancouver
Toloi DA, Critchi G, Mangabeira A, Hoff PM, Matsushita F, Saad ED, Riechelmann RP. Living better or living longer? perceptions of patients (PTS) and health care professionals (HCP) in ONCOLOGY [Internet]. Annals of Oncology. 2014 ; 25 iv483.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1093/annonc/mdu352.7 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.1093/annonc/mdu352.7 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
